1. Research Informatics In The Cloud: Are You Ready?

    Join BIOVIA for a complimentary lunch in Princeton, NJ (Nov 15) or Boston, MA (Nov 16) and learn how BIOVIA is helping pharma, biotech and agrochemical organizations execute on their cloud strategy to become more agile, lower total cost of ownership and collaborate more effectively.

  2. Praxair ControLyo™ Technology: Controlling Nucleation In Commercial Lyophilization

    Praxair’s ControLyo™ technology is a critical, quality driven, cost-saving tool that is becoming the cornerstone of pharmaceutical freeze drying applications. It is a novel and scalable method for controlling nucleation during the freezing step in commercial lyophilization. By introducing a carefully timed depressurization event during the freezing cycle, nucleation will occur simultaneously in all vials. Relying on pressure control, the ControLyo technology is highly adaptable and can be retrofitted to most freeze dryers with minimal impact on established lyophilization protocols. And ControLyo technology does not require any changes to existing drug formulations.

  3. Speed Up The Pace Of Chemical Research And Development

    Today’s chemical development labs are busy places that create fascinating new chemicals, new formulations and new products that boost the bottom line. But are these labs as efficient as they could be?

  4. Improving Green Chemistry With An Electronic Lab Notebook
    The drive toward sustainable, “green” processes in biopharmaceuticals seems like a daunting challenge. However, the right tools can integrate “green” practices into every aspect of the development workflow. This case study explores how one BIOVIA customer rolled out BIOVIA Workbook across its process chemistry division to around 1,000 scientists and the “green” benefits the group saw.
  5. VOYAGER II Adjustable Tip Spacing Pipette Brochure

    Moving multiple samples from one labware to another as individual transfers is both a tedious and an error prone task.

  6. VOYAGER II Adjustable Tip Spacing Pipette

    INTEGRA's VOYAGER II pipettes feature a unique motorized tip spacing, enabling parallel transfer of multiple samples between labware of different sizes and formats. The tip spacing can be changed by a simple push of a button. No manual adjustments or two handed operations are needed.

  7. Accelerate Liquid Transfers Between Different Labware Formats

    INTEGRA has prepared an explanatory application guide that demonstrates the benefits of its electronic adjustable tip spacing VOYAGER II pipette range. Learn how to significantly reduce your pipetting hours and minimize transfer errors when pipetting liquids between tubes, vials and microplates. Example applications covered in the new application guide include screening compound libraries, genotyping, qPCR and cell seeding.

  8. Accelerate Time To Market With And Electronic Lab Notebook

    This white paper examines the challenges of managing research data today and what to look for in an ELN. The white paper also addresses key issues in selecting and deploying an ELN in today’s digital research environment including the importance of seamlessly integrating ELNs with existing research workflows. The white paper concludes with a brief consideration of ELN costs, financial benefits and return on investment (ROI).

  9. Liquid Transfers Application Guide

    Many laboratory applications require liquid transfers between various labware formats. Due to varying requirements in their sample processing, different labware vessels are typically used for sample storage, processing and analysis tasks. Traditional multichannel pipettes were not designed to accommodate this wide variety of labware formats because their tip to tip spacing is optimized for use with standard 96 well microplates.

  10. Accelerating Biopharmaceutical Development From DNA To Drug

    The pipeline of biopharmaceutical drugs is rich and becoming increasingly diverse. Many new biologic modalities are being developed as established therapeutic classes move through their lifecycle. Wide arrays of different types of molecules are expected to coexist within product portfolios and manufacturing networks. It is clear that this will have a significant impact on manufacturing facilities. Strategies need to be developed to prepare facilities for these challenges.